Early abiraterone acetate treatment is beneficial in Japanese castration-resistant prostate cancer after failure of primary combined androgen blockade

BACKGROUND: Development of novel agents targeting the androgen axis has led to improved overall survival in castration-resistant prostate cancer (CRPC). This study aimed to investigate the optimal timing of treatment with one such agent, abiraterone acetate (AA), in Japanese patients. MATERIALS AND...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Prostate Int
Hoofdauteurs: Nagai, Takashi, Naiki, Taku, Iida, Keitaro, Etani, Toshiki, Ando, Ryosuke, Hamamoto, Shuzo, Sugiyama, Yosuke, Akita, Hidetoshi, Kubota, Hiroki, Hashimoto, Yoshihiro, Kawai, Noriyasu, Yasui, Takahiro
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Asian Pacific Prostate Society 2018
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5857185/
https://ncbi.nlm.nih.gov/pubmed/29556485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.prnil.2017.07.001
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items